NanoVita Raises $10M Seed Before BNB Token Launch
NanoVita closed a $10M seed round at $10M FDV, led by CGV. The DeSci project plans a BNB Chain token launch in late April.
NanoVitaTL;DR:
- DeSci projects continue to attract funding, with this round adding to recent sector activity
- Investors are backing early-stage health-data protocols despite limited third-party verification
- Initial reports called this a Series A, but sources confirm it was a seed round
- The BNB Chain token launch is scheduled for late April, with Alpha Pass NFTs available beforehand
- Token economics and governance details should become clearer after the launch
DeSci Protocol Closes Funding Round
NanoVita, a decentralized science project working on health data infrastructure, has raised funding to support its open research platform. The project combines nanotechnology, AI, and blockchain to let users share and benefit from health data. DeSci protocols have gained attention in Web3 as alternatives to traditional research funding and data ownership models.
The round was announced in late March 2026. Initial reports described it as a Series A, but multiple sources confirm this was actually a seed round—no evidence of a separate Series A exists. The funding comes ahead of a token generation event on BNB Chain planned for late April 2026.
| Funding Details | Information | |-------------------|---------| | Project | NanoVita | | Sector | DeSci / Health Research | | Round Type | Seed (initially misreported as Series A) | | Amount | $10 million | | Valuation | $10 million FDV | | Lead Investor | Cryptogram Venture (CGV) | | Other Investors | UNIVERSE-DIMENSIONAL SPACE PTE. LTD., Candaq Fintech Group, Susie Ventures; K24 Ventures mentioned but not confirmed | | Information Gaps | No confirmed use of funds; some investor details unverified |
CGV led the round, with participation from UNIVERSE-DIMENSIONAL SPACE (Singapore), Candaq Fintech Group, and Susie Ventures (BVI). The round closed March 31, 2026. K24 Ventures appeared in an April 6 social media post but hasn't been confirmed in official announcements. Before the token launch, NanoVita plans to sell Alpha Pass NFTs that include token airdrops, hardware (smart masks), DAO voting rights, and rewards for contributing data.
NanoVita doesn't appear on Crunchbase or other mainstream venture trackers—coverage has come entirely from crypto-focused outlets. This is typical for early-stage Web3 projects that haven't yet built visibility outside the space.
What the Token Launch Means
The BNB Chain token launch is the next major milestone. Alpha Pass NFTs will give holders early access to the network. If the launch goes well, it could bring more attention to decentralized approaches for managing health research data.
- Who invested: The backers are mostly crypto-native funds with Asian and fintech connections. CGV took the lead.
- What the money is for: Building out the health data platform, though specific plans haven't been disclosed.
- Where this fits: DeSci is still a small category, but it's growing. These projects use blockchain to make research funding and data sharing more transparent.
- What we couldn't verify: K24 Ventures' role comes from a single social post. Other investors have more documentation.
The project's technical description is consistent across sources. The main reporting issue was the seed-vs-Series-A confusion, plus incomplete investor confirmation—both common problems in early Web3 coverage. As of April 6, 2026, NanoVita is one of several DeSci projects moving from funding announcements toward token launches.
The $10M round is relatively small, but it puts NanoVita in a growing group of protocols trying to change how health data gets shared and monetized. The token launch should answer open questions about economics and governance.
Bottom line: Early DeSci projects are still finding investors, even when verification is incomplete and visibility is limited to crypto media.